August 2025’s Asian Stock Picks For Estimated Value Opportunities
4 Mins Read
As global trade tensions and economic uncertainties weigh on markets, Asian indices have experienced mixed performances, with China’s economy showing signs of slowing growth and Japan’s market facing renewed pressure from international developments. In this environment, identifying undervalued stocks in Asia could present potential opportunities for investors seeking to capitalize on discrepancies between market price and intrinsic value.
We’re going to check out a few of the best picks from our screener tool.
Overview: LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing medicines for unmet medical needs and has a market capitalization of approximately ₩5.41 trillion.
Operations: The company’s revenue is primarily derived from its Pharmaceutical Business segment, which generated approximately ₩20.86 billion, and its New Drug Research and Development segment, contributing around ₩125.56 billion.
Estimated Discount To Fair Value: 48.4%
LigaChem Biosciences is trading at ₩149,100, significantly below its estimated fair value of ₩288,985.41. Despite recent share price volatility and low forecasted return on equity (7.4%), the company has become profitable this year with earnings expected to grow 50.5% annually, outpacing the KR market’s 22.2%. Recent developments include a completed share buyback and ongoing Phase 1 trials for LNCB74 targeting advanced solid tumors, highlighting potential growth avenues amid robust cash flow prospects.
KOSDAQ:A141080 Discounted Cash Flow as at Aug 2025
Overview: Beijing Zhong Ke San Huan High-Tech Co., Ltd. operates in the high-tech sector, focusing on the production and development of advanced magnetic materials, with a market cap of CN¥16.90 billion.
Operations: Beijing Zhong Ke San Huan High-Tech Co., Ltd. generates its revenue primarily from the production and development of advanced magnetic materials.
Estimated Discount To Fair Value: 25.1%
Beijing Zhong Ke San Huan High-Tech is currently trading at CNY 14.04, well below its estimated fair value of CNY 18.75. The company reported a turnaround with net income of CNY 43.99 million for the first half of 2025, compared to a loss last year, indicating improved financial health despite recent sales decline. Earnings are forecasted to grow significantly at 46.8% annually over the next three years, surpassing market averages and suggesting strong cash flow potential amidst low return on equity forecasts.
SZSE:000970 Discounted Cash Flow as at Aug 2025
Overview: Silergy Corp. designs, manufactures, and sells integrated circuit products and related technical services in China and internationally, with a market cap of NT$129.60 billion.
Operations: The company’s revenue is primarily derived from its semiconductors segment, which generated NT$18.71 billion.
Estimated Discount To Fair Value: 33%
Silergy is trading at NT$335, significantly below its estimated fair value of NT$500.22, highlighting potential undervaluation based on cash flows. The company reported strong Q1 2025 results with net income rising to TWD 358.56 million from TWD 78.01 million a year ago, suggesting robust financial performance despite a low forecasted return on equity of 14.9% in three years. Recent board changes may influence strategic direction positively amidst expected significant earnings growth of 34.1% annually over the next three years.
TWSE:6415 Discounted Cash Flow as at Aug 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A141080 SZSE:000970 and TWSE:6415.
This article was originally published by Simply Wall St.
